Elanco Animal Health Incorporated kicked off the trading day on 08/14/19 with a price decrease of -4.49%, equivalent to -$1.34 relative change for the day. Taking a more long-term approach, ELAN had a 52-week range of $28.00 to $37.61. At the time of this article’s publishing, this stock is trading at $28.51 after starting the trading session at $29.04.At the time of writing, this stock’s 50-day Moving Average stands at $32.86, while the 200-day Moving Average of this stock is currently $32.03.
Currently, this company’s share volume is sitting at $4,904,207, but has maintained average daily volume of $2.82M. This stock has generated an average Year to Date volume of $5.81 million, alongside an average 20-day volume of $2.84 million. This publicly-traded company’s shares outstanding now amounts to $381.24 million, simultaneously with a float of $372.03 million. The organization now has a market capitalization sitting at $10.87 billion.
Elanco Animal Health Incorporated(ELAN) Ownership Data
If we take a glance at the Ownership summary of Elanco Animal Health Incorporated’s stock, 456 Institutional holders make up 102.54% of its total stock ownership. All together, they are the legal holders of 382,479,364 shares, which are valued at about $11,417,009,015 in total. If we focus on the top 3 stockholders for this publicly-traded organization, PRICE T ROWE ASSOCIATES INC /MD/ owns 38.68 million shares, with PRIMECAP MANAGEMENT CO/CA/ in 2nd place owning 30.61 million shares and VANGUARD GROUP INC in third place with total ownership of 29.35 million shares.
Elanco Animal Health Incorporated (ELAN) Earnings and Revenue Data
In the latest quarterly report that this company released, which was put into the public domain on Jun-19, the organization reported $0.28 earnings per share (EPS) for the three-month period, surpassing the consensus estimate (set at $0.26) by $0.02.
The corporation racked down revenue of $731.10million for the previous financial quarter, compared to the mean analyst estimate of $743.53 million. This company achieved a net margin of 1.48 while generating a return on equity of 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.27 per share during the current fiscal year.
Elanco Animal Health Incorporated’s EPS increase for this current 12-month fiscal period is 124.50%, and is forecasted to reach 17.60% in the upcoming year. Looking at the long run, market analysts have predicted that Company’s EPS will increase by 12.76% through the next 5 years, which can be compared against the -15.10% growth it accomplished over the previous five years trading on the market.
Additional Trading Performance Indicators
Now turning our attention to the current performance indicators for Elanco Animal Health Incorporated, this organization’s Quick Ratio in the last reported quarter now stands at 1.80. The company has managed to achieve an average true range (ATR) of 1.19. Alongside those, its PE Ratio stands at $375.13.
Another valuable indicator worth considering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.55 for this organization. Plus, this company’s price to book ratio for the last three-month fiscal period reported is 2.01, whereas its price to cash per share for the last quarter landed at 0.71.
In the same vein, ELAN’s Diluted EPS (Earnings per Share) trailing twelve month was posted at 0.08, a figure that is expected to reach 0.26 in the next reported quarter, and analysts expect it will be 17.60% at the market close of one year from today’s date.